1 |
Polack FP, Thomas SJ, Kitchin N, et al. (2020). Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine, The New England Journal of Medicine, 383, 2603-2615.(DOI: 10.1056/NEJMoa2034577)
DOI
|
2 |
Voysey M, Clemens SAC, Madhi SA, et al. (2021). Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK, Lancet, 397, 99-111.
DOI
|
3 |
Baden LR, El Sahly HM, Essink B, et al. (2021). Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine, The New England Journal of Medicine, 384, 403-416. (DOI: 10.1056/NEJMoa2035389)
DOI
|
4 |
CDC (2012). Principles of Epidemiology in in Public Health Practice 3th Ed, 3-48 - 3-50, Atlanta, GA.
|
5 |
National Institute of Food and Drug Safety Evaluation (2021). Considerations in COVID-19 vaccines development.
|